FDA Described as “Clown Show” Amid Latest Scandal; Top Drug Regulator Is Out

FDA drug chief’s ‘revenge’ emails revealed in explosive lawsuit

A lawsuit alleges that the FDA’s top drug regulator allowed personal grudges to influence policy.

FDA described as “clown show” amid latest scandal; top drug regulator is out

FDA regulator accused of using position to exact revenge on old business associate.

How George Tidmarsh crossed the FDA-industry Rubicon

To say that it has been an eventful few months for George Tidmarsh would be a bit of an understatement. This content is for Group 1 - Individual Seat, Individual Subscription - Annual ($555), Individual Subscription - Monthly ($55), Introductory Subscription - non-renewing ($60), and Sponsored account members only. Visit the site and log in/register to read.The post How George Tidmarsh crossed the FDA-industry Rubicon appeared first on The Cance…

FDA Activity Recap: October 2025 Features New Platform Technology Designation, RDEA Pilot Program Selection, and More – automotivemogul

Last month, October 2025, the CGTLive® team was diligently tracking the FDA’s activities related to the development of cell and gene therapies for the treatment of rare, complex, and otherwise challenging diseases and disorders. The agency has continued to …

FDA Drug Unit chief resigns as he is sued

George Tidmarsh, the head of the FDA’s drug division, resigned on Sunday after he was placed on leave Friday, “after the Office of the General Counsel and the Office of the Inspector General were notified of serious concerns about his personal conduct,” Emily Hilliard, an HHS spokeswoman, told ABC News in a statement. Tidmarsh said… The post FDA Drug Unit chief resigns as he is sued appeared first on Drug Discovery and Development.

FDA Official Steps Down, Sued by Drugmaker

(WSJ) – George Tidmarsh, who resigned Sunday, is accused in a lawsuit of seeking a bribe and defaming a drug A Food and Drug Administration official who resigned on Sunday was sued by a Canadian pharmaceutical company, which accused him of soliciting a bribe and tanking its stock with false statements as part of a revenge campaign against a former colleague. (Read More)